Stock Dividend Profile

Hikma Pharmaceuticals PLC

HIK.LSE LSE GBX ISIN GB00B0LCW083
Open 1,589.00p Prev close 1,579.00p Volume 525,015
Frequency Semi-annual 2 events in last 12m
Trend Growing 2022-2026 payout trend
Volatility 16.04% annual payout CV
Growth 11.27% annualised payout

Yield Pulse

Next Event Forecast
~2.30% 37.2p
final
0%
Awaiting declaration Ex 19 Mar · 163 days to go
Next Event · Detail
Forecast Declaration Date 02 Mar 2027
Forecast ex-div date19 Mar
Countdown163 days to go
Amount37.2p final
TTM
3.97% 64.4p
ttm total
0%
2 payments last 17 sep
TTM · Detail
30 Apr Regular 35.3p
17 Sep Regular 29.1p
TTM + Specials
3.97% 64.4p
ttm+sp total
0%
2 payments last 17 sep
TTM + Specials · Detail
30 Apr Regular 35.3p
17 Sep Regular 29.1p
No specials in the last 12 months
Forward
4.28% 69.4p
fwd total
0%
2 payments next 27 apr
Forward · Detail
27 Apr Final forecast 37.2p
21 Sep Interim forecast 32.2p

Next Dividends

1 19 Mar 2027 Forecast
37.2p Final
Yield 2.30%
Pay 25 Apr 2027 Decl 02 Mar 2027
2 13 Aug 2027 Forecast
32.2p Interim
Yield 1.99%
Pay 19 Sep 2027 Decl 27 Jul 2027

Dividends

Trade analysis
Dividend27.1pInterim Event yield1.50% – 1.56%declared to ex-div Ex-div drop-1.21%price move Decl07 Aug Ex-div14 Aug Pay18 Sep
Dividend35.3pFinal Event yield2.57% – 2.96%declared to ex-div Ex-div drop-3.11%price move Decl26 Feb Ex-div19 Mar Pay30 Apr
Dividend29.1pInterim Event yield1.71% – 1.78%declared to ex-div Ex-div drop-0.24%price move Decl06 Aug Ex-div13 Aug Pay17 Sep
Price History 21 Mar 2025 to 06 Oct 2026
History dividend: 14 Aug 2025 | Declared: 07 Aug 2025 | Dividend: 27.1p | Yield before ex: 1.50% | Ex-drop: -1.21% | Window yield range: 1.50% to 1.56% History dividend: 19 Mar 2026 | Declared: 26 Feb 2026 | Dividend: 35.3p | Yield before ex: 2.75% | Ex-drop: -3.11% | Window yield range: 2.57% to 2.96% History dividend: 13 Aug 2026 | Declared: 06 Aug 2026 | Dividend: 29.1p | Yield before ex: 1.77% | Ex-drop: -0.24% | Window yield range: 1.71% to 1.78% 1,114.44 1,391.97 1,669.50 1,947.03 2,224.56 Apr 25 Jul 25 Oct 25 Jan 26 Apr 26 Jul 26 Oct 26 Decl 07 Aug Ex 14 Aug Pay 18 Sep Decl 26 Feb Ex 19 Mar Pay 30 Apr Decl 06 Aug Ex 13 Aug Pay 17 Sep
27.1p Interim
Declared
07 Aug
Ex-div
14 Aug
Yield
1.50%–1.56%
Ex-drop
-1.21%
Paid
18 Sep
35.3p Final
Declared
26 Feb
Ex-div
19 Mar
Yield
2.57%–2.96%
Ex-drop
-3.11%
Paid
30 Apr
29.1p Interim
Declared
06 Aug
Ex-div
13 Aug
Yield
1.71%–1.78%
Ex-drop
-0.24%
Paid
17 Sep
Forecast
37.2p Final
Declared
02 Mar 2027
Ex-div
19 Mar 2027
Pay
25 Apr 2027
Yield
2.30%
Forecast
32.2p Interim
Declared
27 Jul 2027
Ex-div
13 Aug 2027
Pay
19 Sep 2027
Yield
1.99%

News

Market tone: Positive · score 0.98 · 1 mention
02 Oct 2026 Positive 0.99 Hikma Pharmaceuticals And 2 British Biotech Stocks To Watch Eurozone inflation recently topped forecasts and hit a three year high, which keeps pressure on central banks and pushes investors toward areas where returns depend more on scienti Animal Genetics Biotech Gene Therapy Pharma 05 Sep 2026 Positive 1.00 Hikma Pharmaceuticals (LSE:HIK) Stock Fair Value Edges Higher After Bullish Analyst Targets Price targets for Hikma Pharmaceuticals are currently clustered in the £1,870 to £2,100 range, which sits above the latest fair value estimate of £19.70. Analysts linking these hig Analyst Ratings Pharma Price Target Price Target 25 Aug 2026 Positive 0.96 Jefferies lifts Hikma target as CMO deal underpins growth story Jefferies lifts Hikma target as CMO deal underpins growth story Proactive uses images sourced from Shutterstock Jefferies has raised its price target on Hikma Pharmaceuticals PLC Contract Manufacturing Earnings Pharmaceuticals Price Target 12 Aug 2026 Positive 0.99 Citi sees Hikma discount as unwarranted after upgrade to forecasts Citi sees Hikma discount as unwarranted after upgrade to forecasts Proactive uses images sourced from Shutterstock Citi has raised its estimates for Hikma Pharmaceuticals PLC (LSE Balance Sheet Dividends Earnings Pharma 06 Aug 2026 Positive 0.99 Hikma jumps 10% as brokers point to profit beat and undemanding rating Hikma jumps 10% as brokers point to profit beat and undemanding rating Proactive uses images sourced from Shutterstock Hikma Pharmaceuticals PLC (LSE:HIK, OTC:HKMPF) shares rose 1 Earnings Earnings Per Share Pharmaceuticals Price Target 22 Jul 2026 Positive 0.97 Hikma recovery story still has further to run after recent rally, says Panmure Hikma recovery story still has further to run after recent rally, says Panmure Proactive uses images sourced from Shutterstock Hikma Pharmaceuticals PLC (LSE:HIK, OTC:HKMPF) has a Earnings Guidance Pharma Price Target

Historical Dividends

Total dividends and yield-at-ex-date by year
Payout trend 14.29% Growing · 2021-2025 payout CAGR
Payout volatility 20.51% Variable · std dev / average payout
Peak payout69.4p
Peak annual yield4.46%
2021
1.58%
37.7p
18 Mar 24.7p 19 Aug 13.0p
2022
2.40%
42.0p
17 Mar 26.0p 18 Aug 16.0p
2023
2.55%
49.4p
23 Mar 29.5p 10 Aug 19.9p
2024
3.11%
61.4p
21 Mar 37.1p 15 Aug 24.3p
2025
3.38%
64.3p
20 Mar 37.2p 14 Aug 27.1p
2026 This year
4.46%
64.4p
19 Mar 35.3p 13 Aug 29.1p
2027 Projection
4.28%
69.4p
19 Mar 37.2p 13 Aug 32.2p
YearEx-dateDeclaredRecordPaymentPeriodValueYield
2027
2027 19 Mar 2027 02 Mar 2027 — — Final Forecast 37.2p Final 2.30%
2027 13 Aug 2027 27 Jul 2027 — — Interim Forecast 32.2p Interim 1.99%
History
2026
2026 13 Aug 2026 06 Aug 2026 - 17 Sep 2026 Interim 29.1p Interim —
2026 19 Mar 2026 26 Feb 2026 - 30 Apr 2026 Final 35.3p Final —
2025
2025 14 Aug 2025 07 Aug 2025 - 18 Sep 2025 Interim 27.1p Interim —
2025 20 Mar 2025 26 Feb 2025 - 01 May 2025 Final 37.2p Final —
2024
2024 15 Aug 2024 08 Aug 2024 15 Aug 2024 20 Sep 2024 Interim 24.3p Interim —
2024 21 Mar 2024 22 Feb 2024 21 Mar 2024 03 May 2024 Final 37.1p Final —
2023
2023 10 Aug 2023 03 Aug 2023 10 Aug 2023 15 Sep 2023 Interim 19.9p Interim —
2023 23 Mar 2023 23 Feb 2023 23 Mar 2023 05 May 2023 Final 29.5p Final —
2022
2022 18 Aug 2022 04 Aug 2022 18 Aug 2022 20 Sep 2022 Interim 16.0p Interim —
2022 17 Mar 2022 24 Feb 2022 17 Mar 2022 28 Apr 2022 Final 26.0p Final —
2021
2021 19 Aug 2021 06 Aug 2021 19 Aug 2021 20 Sep 2021 Interim 13.0p Interim —
2021 18 Mar 2021 25 Feb 2021 18 Mar 2021 26 Apr 2021 Final 24.7p Final —
2020
2020 20 Aug 2020 07 Aug 2020 20 Aug 2020 21 Sep 2020 Interim 12.0p Interim —
2020 19 Mar 2020 27 Feb 2020 19 Mar 2020 07 May 2020 Final 24.2p Final —

Upcoming Dividends

Declared and forecast dividend cycle
Ex-dateStatusPeriodDividendYield
19 Mar 2027 Forecast Final Forecast 37.2p Final 2.30%
13 Aug 2027 Forecast Interim Forecast 32.2p Interim 1.99%

Recovery Speed

Recovered by trading week
1w
2 <= 5d trading days
2w
3 <= 10d trading days
3w
3 <= 15d trading days
4w
3 <= 20d trading days
5w
3 <= 25d trading days
6w
4 <= 30d trading days

Recovery Signature

Post ex-div behaviour
Median recovery6dtrading days to regain pre-ex close
Recovered66.67%events recovered inside 6w
Drop capture103.72%ex-drop as share of dividend paid
Score59speed, consistency, and drift blend
+15% +5% 0% -5% -15% Ex 1w 2w 3w 4w 5w 6w
Bold white line = average visible recovery curve 6 events selected